Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Company Highlights for Sept 2, 2010, From CRWENewsxwire - Healthmed Services Ltd., HEME.OB; Medicis Pharmaceutical, MRX; HealthSpring Inc, HS

|Includes: CI, Valeant Pharmaceuticals International, Inc. (VRX) HealthMed Services LTD, HEME.OB

Charting a New Course in Saving Lives

HealthMed Services LTD (HEME.OB) is a company for the record.

HealthMed, an innovative software development company, is pleased to announced today that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware.

Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.

Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.

The software is based on plug-in architecture allowing easy implementation of new features. There are five basic modules: Speech module - text input for speech replacement; GSM module - send and receive SMS; MSN module; Windows Live Messenger chat Book Reader - reading books by speech synthesis; and Web Browsing - special plug-ins for Bing Maps and Facebook.

The developers of the software and hardware will continue to work with HealthMed on an outsourcing basis in developing further applications for the Neural Communicator.

HealthMed, a development stage company is developing a revolutionary new remote software product called Virtual Vantage that will simplify record- keeping and mobilize healthcare professionals. This software will increase efficiency of staff by allowing them to interact with their stationary PC from anywhere within the facility. Therefore, electronic charting and updating patient records will alleviate the workload of healthcare professionals.

HeatlthMed also intends to provide individuals, companies, and health-provider organizations with telephone and Web-based access to medical advice, information, and products and services in the United States and internationally.

More Information On HealthMed Can Be Found At:


mrx_logo Medicis Pharmaceutical, MRX

It's the scourge of teenagers everywhere. But for Medicis Pharmaceutical (NYSE:MRX), acne is no curse. It's a multibillion-dollar-a-year market opportunity.

Medicis develops and markets various drugs, gels and creams to treat a range of dermatological and aesthetic conditions. Its focus is helping people look healthy and youthful.

The 22-year-old company also has wrinkle-fighting products for older adults, and is working on U.S. regulatory approval for a device that uses ultrasound to attack fat cells beneath the skin.

Making wrinkles go away is a growth market, with demographics giving a boost. Baby boomers are already shelling out money to look young. And their children, the so-called echo boomers, are creeping into their 30s now, heading toward their first laugh lines.

Acne Creams

But those prescription acne creams and treatments are still the main driver at Medicis, accounting for almost 70% of last year's $572 million in sales. Medicis thinks Americans alone will spend $5.8 billion this year to treat acne and other dermatological conditions.

Medicis Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States, Canada, and Europe. The company's products address various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis, and cosmesis.

For More Information On Medicis Visit Their Website:


Managed care company HealthSpring Inc (NYSE:HS) said it agreed to pay $545 million to acquire a privately held operator of Medicare plans to gain access to customers who are not bound by enrollment restrictions, driving its shares up to a 52-week high.

The acquisition of Bravo Health Inc also comes with the Baltimore-based company's strong presence in the Philadelphia and Texas markets.

"Approximately 50 percent of the Bravo members are dual eligible beneficiaries who are not confined to strict annual enrollment periods that non-dual eligible Medicare members face and therefore can enroll with plans at any point throughout the year," HealthSpring Chief Executive Herb Fritch said.

The recently passed U.S. healthcare reform bill will restrict, from the next enrollment year, the period and options for Medicare beneficiaries to change their plans, once they have signed on for the year.

The deal will hurt HealthSpring's 2010 earnings by about 20 cents a share, but add between 45-55 cents to its 2011 earnings, the company said in a statement. The transaction will be financed through cash and debt under an amended revolving credit facility and new term loans.

HealthSpring, Inc., through its subsidiaries, operates as a managed care organization in the United States. It focuses primarily on Medicare, the federal government sponsored health insurance program for the U. S. citizens aged 65 and older, qualifying disabled persons, and persons suffering from end stage renal disease in the states of Alabama, Florida, Illinois, Mississippi, Tennessee, and Texas. The company also provides management services to healthcare plans and physician partnerships

Visit HealthSpring's website to find out more:




The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.(OTCPK:CRWE) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)